POLG2

Chr 17ARAD

DNA polymerase gamma 2, accessory subunit

Also known as: HP55, MTDPS16, MTDPS16A, MTDPS16B, MTPOLB, PEOA4, POLG-BETA, POLGB

This gene encodes the processivity subunit of the mitochondrial DNA polymerase gamma. The encoded protein forms a heterotrimer containing one catalytic subunit and two processivity subunits. This protein enhances DNA binding and promotes processive DNA synthesis. Mutations in this gene result in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions.[provided by RefSeq, Sep 2009]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismAR/ADLOEUF 1.063 OMIM phenotypes
Clinical SummaryPOLG2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
33 unique Pathogenic / Likely Pathogenic· 326 VUS of 580 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — POLG2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.06LOEUF
pLI 0.000
Z-score 1.32
OE 0.72 (0.501.06)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.35Z-score
OE missense 1.06 (0.961.17)
270 obs / 254.4 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.72 (0.501.06)
00.351.4
Missense OE?1.06 (0.961.17)
00.61.4
Synonymous OE?1.04
01.21.6
LoF obs/exp: 19 / 26.3Missense obs/exp: 270 / 254.4Syn Z: -0.34

This gene — mechanism propensity

DN
0.5378th %ile
GOF
0.2796th %ile
LOF
0.4332th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF1 literature citation · 94% of P/LP variants are LoF
DN1 literature citation

Literature Evidence

DNPOLG2 disease variants: analyses reveal a dominant negative heterodimer, altered mitochondrial localization and impaired respiratory capacity.1
LOFAlthough the WT component of p55 dimers within the mitochondria of an individual heterozygous for POLG2 cannot easily be determined, the failure of our mixing experiments to reveal a dominant negative effect in vitro suggests that the phenotype of the affected heterozygote may be due to simple haplo2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

580 submitted variants in ClinVar

Classification Summary

Pathogenic21
Likely Pathogenic12
VUS326
Likely Benign166
Benign20
Conflicting30
21
Pathogenic
12
Likely Pathogenic
326
VUS
166
Likely Benign
20
Benign
30
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
20
1
0
0
21
Likely Pathogenic
11
1
0
0
12
VUS
17
288
17
4
326
Likely Benign
0
8
58
100
166
Benign
0
2
16
2
20
Conflicting
30
Total4830091106575

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

9 pathogenic / likely-pathogenic (of 12) ClinVar copy-number / structural variants overlap POLG2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

POLG2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.